Wells Fargo analyst Mohit Bansal lowered the firm’s price target on Bristol Myers (BMY) to $60 from $65 and keeps an Equal ...

Pfizer is rated a Buy with new and acquired products generated $3.2B in Q2, growing 18% YoY and $13B annualized run-rate.

Bristol-Myers Squibb is a Hold as replacing lost revenue from Eliquis and Opdivo presents a significant challenge. Click here ...

A brief research report found that Medicare beneficiaries taking several commonly prescribed medications could see ...

Johnson & Johnson trades at a higher valuation with growing sales, while Pfizer's dividend yield is near 6% as patents expire from 2026 through 2030.

Popular biopharmaceutical company Pfizer (PFE) plans to cut around 330 jobs at its Catania plant in Sicily. This is part of a ...

A new rule from Customs and Border Protection could force Americans who import medicine to save money.

PFE moves above its 50-day SMA as newer drugs, oncology and obesity treatments fuel growth prospects, but declining COVID ...

- Bristol Myers BMY-0.77% (BMY) and Novo Nordisk NVO+1.20% (NVO) trade at similar low P/E ratios but reflect divergent risks: ...

New customs requirements taking effect Oct. 22 could disrupt prescription deliveries for patients who rely on lower-cost ...

Chenault takes a few drops of Vyzulta, a glaucoma medication, every day. By ordering it from a pharmacy in Canada, she saves ...

Millions of Americans who buy cheap drugs from Canada could soon lose access when a customs rule goes into effect later this ...